University of Minnesota. Driven to Discover.
(CIDRAP News) The US Department of Health and Human Services (HHS) has awarded a contract to a San Francisco company to further the development of a new broad-spectrum antibiotic for treating plague, tularemia, and various resistant infections.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.